蛋白质组学与栓塞性及血栓性卒中风险
基于ARIC队列,利用SomaScan检测中晚年血浆蛋白,分析其与新发栓塞性卒中(EIS)和血栓性卒中(TIS)的关联。中晚年分别发现20和4种蛋白与卒中相关,NPPB与EIS特异相关,19种中晚年蛋白主要与TIS相关,提示不同卒中机制。
要点
- NPPB与中晚年EIS风险显著相关,但与TIS无关。
- 19种中晚年蛋白主要与TIS风险相关,部分与EIS仅名义相关。
- EIS相关蛋白涉及癌症通路,TIS相关蛋白反映细胞结构与动脉粥样硬化。
核心结论
- 血浆蛋白与EIS和TIS风险关联反映不同卒中机制:EIS以心脏功能障碍蛋白(如NPPB)为特征,TIS以炎症失调(如白介素)为特征。
研究设计与样本
- ARIC队列研究,纳入V2(1990-1992)无卒中且有SomaScan数据者10929人,V5(2011-2013)再次检测者4463人,随访至2020年。
主要发现
- 中晚年20种蛋白与EIS(n=168)或TIS(n=459)相关,晚年4种蛋白与晚年卒中(73例EIS,124例TIS)相关,Bonferroni阈值p<1E-5。
- 中晚年NPPB与EIS显著相关,与TIS无关(p-difference=9.14E-7)。
- 中晚年19种蛋白与TIS强相关:7种与TIS强相关且与EIS仅名义相关(p<0.05),12种仅与TIS相关。
- 晚年NPPB、丝氨酸蛋白酶抑制剂Kazal型4、少突胶质细胞-髓鞘糖蛋白、neurocan核心蛋白与EIS显著相关,与TIS无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Personalized approaches to ischemic stroke diagnosis are needed. We determine differences in proteomic signatures of incident embolic (EIS) and thrombotic stroke (TIS) by age and resultant pathways using large-scale proteomics. METHODS: Participants in the Atherosclerosis Risk in Communities Study (ARIC) from visit 2 (V2, 1990-1992) until 2020 without prevalent stroke with available SomaScan data (4,955 protein targets) at V2 (mid-life, n = 10,929), and then again at visit 5 (V5, 2011-2013, n = 4,463) were included. Covariate adjusted Cox hazard models determined the association between proteins, and adjudicated incident EIS or TIS from V2 to V5 and from V5 to 2020. RESULTS: Among 10,929 participants (56% female, 23% Black, follow-up ~20 years), 20 proteins measured in mid-life were associated with either EIS (n = 168) or TIS (n = 459) in mid-life, and 4 measured in late-life were associated with late-life stroke (73 EIS and 124 TIS events) at the Bonferroni threshold p < 1E-5. In mid-life, N-terminal pro-B-type natriuretic peptide (NPPB) was significantly associated with EIS, but not TIS (p-difference = 9.14E-7). Nineteen mid-life proteins were strongly associated with TIS; 7 strongly associated with TIS and only nominally (p < 0.05) with EIS and the remaining 12 with TIS only. In late-life, NPPB, serine protease inhibitor Kazal-type 4, oligodendrocyte-myelin-glycoprotein, and neurocan-core protein were significantly associated with EIS, but not TIS. Ingenuity Pathway Analysis tools implicated cancer for EIS-associated proteins, whereas TIS pathways reflected cell-structure and atherogenesis. INTERPRETATION: We identified plasma proteins associated with risk of EIS versus TIS reflecting distinct stroke mechanisms: cardiac dysfunction protein in EIS (eg, NPPB) and inflammation dysregulation in TIS (eg, interleukins). ANN NEUROL 2025;98:1125-1135.
引用
- Johansen MC, Chen J, Walker KA, et al. Proteomics and the Risk of Incident Embolic and Thrombotic Stroke. Ann Neurol. 2025. PMID: 40757626. doi:10.1002/ana.70011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。